Advisor Group’s Vertex Pharmaceuticals VRTX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2019
Q4
$3.59M Buy
16,412
+7,529
+85% +$1.52M 0.02% 537
2019
Q3
$1.5M Sell
8,883
-3,048
-26% -$539K 0.01% 911
2019
Q2
$2.19M Sell
11,931
-1,121
-9% -$196K 0.02% 720
2019
Q1
$2.4M Buy
13,052
+4,405
+51% +$814K 0.02% 652
2018
Q4
$1.43M Sell
8,647
-1,239
-13% -$215K 0.01% 764
2018
Q3
$1.91M Buy
9,886
+4,783
+94% +$852K 0.02% 657
2018
Q2
$866K Buy
5,103
+326
+7% +$50.5K 0.01% 947
2018
Q1
$778K Sell
4,777
-421
-8% -$68.8K 0.01% 1020
2017
Q4
$779K Sell
5,198
-75
-1% -$11.1K 0.01% 1050
2017
Q3
$802K Buy
5,273
+274
+5% +$41.2K 0.01% 927
2017
Q2
$644K Buy
4,999
+593
+13% +$71.4K 0.01% 995
2017
Q1
$481K Buy
4,406
+63
+1% +$5.55K 0.01% 1102
2016
Q4
$319K Buy
4,343
+69
+2% +$5.61K 0.01% 1271
2016
Q3
$372K Buy
4,274
+245
+6% +$23.2K 0.01% 1139
2016
Q2
$344K Buy
+4,029
New +$348K 0.01% 1123

Other funds holding VRTX